LAKE OSWEGO, Ore., BIOTRONIK, a leader in cardio- and endovascular medical technology, today announced Food and Drug Administration (FDA) approval of BioMonitor 2, an insertable cardiac remote monitor ...
LAKE OSWEGO, Ore-- BIOTRONIK today announced FDA clearance of the BIOMONITOR III injectable cardiac monitor (ICM). BIOMONITOR III is designed to document suspected arrhythmia or unexplained syncope ...
BERLIN--(Marketwire - Oct 11, 2012) - BIOTRONIK, a leading manufacturer of medical technology, today announced the European market release of BioMonitor ®, a unique implantable cardiac device designed ...
BERLIN--(BUSINESS WIRE)--BIOTRONIK today announced the market release of its new injectable cardiac monitor (ICM), BIOMONITOR III, following approval in the CE region. The novel device is designed to ...
Biomonitor A/S has completed the acquisition of the Irish company Neutekbio Ltd. on 27 November 2008. Neutekbio's technologies and products complement Biomonitor’s current offerings to physicians and ...
Biotronik, a leading manufacturer of cardio- and endovascular medical technology, has received CE approval for its BioMonitor 2 implantable continuous wireless cardiac monitor. According to the ...
LONDON, July 28, 2021 /PRNewswire/ -- Based on its recent analysis of the Global market for implantable cardiac monitoring devices, Frost & Sullivan recognizes BIOTRONIK with the 2021 Global Enabling ...
In Biotronik GmbH & Co v OHIM, the CFI has upheld a decision of the Fourth Board of Appeal of OHIM in which the latter had held that the trademark BIOMONITOR is descriptive. Among other things, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results